is there a glp 1 oral medication Article » PBD Injectable vs Oral GLP-1: Comparing

This is why retatrutide is new and different

These next-generation agents engage not only GLP-1 receptors but also those for other gastro-entero-pancreatic hormones such as glucose-dependent insulinotropic polypeptide (GIP), glucagon, amylin, and peptide YY to enhance energy uptake, storage, and expenditure through synergistic mechanisms

Many patients experience reduced appetite and fluid intake when starting GLP-1 therapy, whilst the medicine's gastrointestinal effects including nausea and occasional vomiting can further affect hydration status

Scott's Perspective Every year, we see exciting advances in obesity medicine , and Retatrutide is one of the most promising medications currently being studied